SCHEMBL6339017

SCHEMBL6339017

CCCCCCC(C)OC(=O)CC

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.65
CNR1 P21554 1/20 0.65
CNR2 P34972 1/20 0.65
LMNA P02545 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.49
NAAA Q02083 2/20 0.48
ACE2 Q9BYF1 1/20 0.44
GPR84 Q9NQS5 3/20 0.44
FFAR1 O14842 1/20 0.44
CA1 P00915 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13126847 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL28763670 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL6897022 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL8994200 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL9447664 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL4805826 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL6906595 1.00 FAAH (0.65) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL28213215 0.98 FAAH (0.62) FAAHCNR1CNR2LMNAALDH1A1
SCHEMBL6789916 0.92 FAAH (0.54) FAAHCNR1CNR2LMNAALDH1A1
Propylene Glycol SCHEMBL1982405 0.91 FAAH (0.56) FAAHCNR1CNR2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115052856-A 3-alkoxybenzamide derivative and pest control agent 组合化学工业株式会社 2022-09-13 CN disclosed
CN-102863328-A Synthesis method of tanshinol BEIJING WELLSO PHARMACEUTICAL CO LTD 2013-01-09 CN disclosed
CN-102227205-A Hydrogel particles KAO CORP 2011-10-26 CN disclosed
CN-101909440-A Therapeutic compounds and their use in treating diseases and disorders MYRIAD GENETICS INC 2010-12-08 CN disclosed
US-20050106192-A1 Synergistically-effective composition of zinc ricinoleate and one or more substituted monocyclic organic compounds and use thereof for preventing and/or suppressing malodors INTERNATIONAL FLAVORS & FRAGRANCES INC. 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050106192-A1 Synergistically-effective composition of zinc ricinoleate and one or more substituted monocyclic organic compounds and use thereof for preventing and/or suppressing malodors MAL2, ME1, MALT1 FAAH 1882/4885CNR1 3296/4885CNR2 3010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.